10x Genomics Statistics
NASDAQ: TXGIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD
51.80-5.58 (-9.72%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
10x Genomics by the numbers
10x Genomics has a market capitalization of $6.81 billion based on 121.46M shares outstanding. With trailing EPS of $-0.52, 10x Genomics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 28.9% below its 50-day average and 19.1% above its 200-day average.
Average daily trading volume is 3.36M shares, or about $173.8 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
TXG valuation vs. peer median
| Metric | TXG | Peer median | Difference |
|---|---|---|---|
| Market cap | $6.81B | $1.32B | +416% |
| Avg. volume | 3.36M | 1.82M | +85% |
Peer median across 8 companies: BRKR, BIO, AVTR, ALMR, CTKB, PACB, NAUT, LAB.
Valuation
- Market cap
- $6.81B
- Price / sales (latest FY)
- 10.60
- EPS (TTM)
- $-0.52
- Shares outstanding
- 121.46M
Price and trading
- Previous close
- 57.38
- Open
- 56.44
- Day range
- 51.30 – 56.44
- 52-week range
- 15.18 – 102.81
- 52-week change
- +182.44%
- Beta
- —
- Volume
- 3.23M
- Average volume
- 3.36M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 6.81B
- Forward Pe
- 597.67
- Eps
- -0.52
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 102.81
- Week52 Low
- 15.18
- Avg Volume
- 3.36M
- Shares Outstanding
- 121.46M
- Ma50
- 72.86
- Ma200
- 43.49
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -49.62%
- Pct From52w Low
- 241.24%